IL15Rβ expression level in CD4 + CD28− T cells was significantly higher than that in CD4 + CD28 + T cells in LN patients, suggesting that CD4 + CD28− T cells had a greater advantage in response to IL-15 compared with CD4 + CD28 + T cells (Fig. 3C). This evidence concerns the gene CD28 and lobular neoplasia.